Ovid Therapeutics OVID
NASDAQ OVID
$2.38 -0.05 (-2.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ovid Therapeutics (OVID) Cash & Current Investments (2016 - 2026)

Updated

Ovid Therapeutics' Cash & Current Investments was $117.22 million in Q2 2026, up 205.7% from $38.35 million a year earlier but down 24.6% from the prior quarter.

Analysis

Ovid Therapeutics (OVID) Cash & Current Investments (2016 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Ovid Therapeutics came in at $69.64 million, up 31.2% from FY2024.

  • Cash & Current Investments shows a five-year compound annual growth rate of -0.7% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $53.08 million in FY2024 (-49.9%), $105.83 million in FY2023 (-18.0%), $129 million in FY2022 (-31.3%) and $187.8 million in FY2021 (+160.7%).
  • Quarterly Cash & Current Investments has moved between $25.6 million (Q3 2025) and $201.8 million (Q3 2021) over five years.
  • Compared with a year earlier, Cash & Current Investments has increased for three straight quarters, with growth averaging 32.4% over the last eight quarters.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q1 2026 (growth of 261.7%); the worst was Q3 2025 (a decline of 59.2%).
  • Per Business Quant data, OVID's Cash & Current Investments in the three quarters before Q2 2026 was $155.52 million (Q1 2026), $69.64 million (Q4 2025) and $25.6 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Ovid Therapeutics 439.72 Mn 71.74 Mn - 117.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 117.22 Mn
Mar 31, 2026 155.52 Mn
Dec 31, 2025 69.64 Mn
Sep 30, 2025 25.60 Mn
Jun 30, 2025 38.35 Mn
Mar 31, 2025 43.00 Mn
Dec 31, 2024 53.08 Mn
Sep 30, 2024 62.71 Mn
Jun 30, 2024 76.97 Mn
Mar 31, 2024 90.26 Mn
Dec 31, 2023 105.83 Mn
Sep 30, 2023 87.07 Mn
Jun 30, 2023 96.52 Mn
Mar 31, 2023 117.72 Mn
Dec 31, 2022 129.00 Mn
Sep 30, 2022 137.86 Mn
Jun 30, 2022 152.37 Mn
Mar 31, 2022 168.60 Mn
Dec 31, 2021 187.80 Mn
Sep 30, 2021 201.80 Mn
API Access

Ovid Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=OVID&period=max&api_key=YOUR_API_KEY